[ad_1]
Dexcom takes G6 CGM to Singapore
World CGM machine maker Dexcom has launched its newest CGM system in Singapore.
Distributed by way of its associate DKSH Singapore, the prick-less Dexcom G6 CGM makes use of a wearable sensor and transmitter to repeatedly measure and ship glucose ranges wirelessly to a appropriate good machine.
It pairs with a companion cell app on iOS and Android units, enabling the sharing of glucose knowledge with as much as ten individuals, together with households and healthcare groups.
The launch of the Dexcom G6 comes after it obtained approval from the Well being Sciences Authority late final 12 months and the current opening of the Dexcom regional headquarter within the nation.
Molbio takes majority stake in digital x-ray maker Prognosys
Indian medical machine unicorn firm Molbio Diagnostics has acquired a 70% stake in Prognosys Medical Methods.
Prognosys develops radiology and fluoroscopy options underneath the Prorad model. It has not too long ago launched a line of digital x-ray items that provides high-quality chest imaging powered by AI.
Its mixture with Molbio’s Truenat testing package will improve the prognosis of lethal communicable and non-communicable illnesses reminiscent of tuberculosis, COVID-19, and different chest-related circumstances in giant populations, based on Molbio. Truenat is a WHO-endorsed point-of-care PCR platform that may display screen over 40 illnesses inside an hour.
2C2P supplies fee capabilities to DKSH’s affected person platform
The healthcare enterprise unit of DKSH Singapore has tapped 2C2P to construct new fee capabilities for its affected person engagement administration platform.
By means of this partnership, sufferers on DKSH’s PSPhere platform can now apply for rebates, instalment plans, and e-wallets in a “safe and compliant” method, based on a press assertion.
[ad_2]
Source link
